NURS6521 / NURS 6521 Advanced Pharmacology

Walden University

Voici les meilleures ressources pour passer NURS6521 / NURS 6521 Advanced Pharmacology. Trouvez guides d'étude pour NURS6521 / NURS 6521 Advanced Pharmacology, notes, devoirs et bien plus encore.

All 9 résultats

Trier par

NURS 6521 Final Exam / NURS6521 Advanced Pharmacology Final Exam Latest 6 New Versions (Total 600 QA)
  • NURS 6521 Final Exam / NURS6521 Advanced Pharmacology Final Exam Latest 6 New Versions (Total 600 QA)

  • Examen • 218 pages • 2023
  •  Question 1 1 out of 1 points A Nurse Practitioner is performing patient education for a woman who has just been prescribed a bisphosphonate. Which of the following diagnostic and history findings would have prompted the woman's care provider to prescribe a bisphosphonate? Selected Answer: Low bone density and a family history of osteoporosis
    (0)
  • €20,52
  • + en savoir plus
NURS 6521 / NURS6521 Advanced Pharmacology Final Exam | 100% Correct| Question and Answers | Latest 2022 / 2023
  • NURS 6521 / NURS6521 Advanced Pharmacology Final Exam | 100% Correct| Question and Answers | Latest 2022 / 2023

  • Examen • 27 pages • 2023
  • NURS 6521 / NURS6521 Advanced Pharmacology Final Exam | 100% Correct| Question and Answers | Latest 2022 / 2023 1. A patient is receiving long-term clindamycin therapy for a life-threatening infection. The nurse will begin by monitoring this drug therapy by obtaining ~ Answer: a baseline CBC 2. A 45-year-old woman with acute leukemia will begin chemotherapy with vincristine. The nurse is aware that vincristine must always be administered. ~ Answer: through a central ...
    (0)
  • €10,49
  • 2x vendu
  • + en savoir plus
NURS 6521 / NURS6521 Advanced Pharmacology Final Exam | Graded A| Question and Answers | Latest 2022 / 2023
  • NURS 6521 / NURS6521 Advanced Pharmacology Final Exam | Graded A| Question and Answers | Latest 2022 / 2023

  • Examen • 24 pages • 2023
  • NURS 6521 / NURS6521 Advanced Pharmacology Final Exam | Graded A| Question and Answers | Latest 2022 / 2023 1. A female patient has follicular non-Hodgkin's lymphoma and is receiving thalidomide (Thalomid). It will be most important for the nurse to monitor this patient for which of the following? ~ Answer: Bleeding 2. A nurse has administered filgrastim to a diverse group of patients in recent months. Which of the following patients should the nurse observe for extremely eleva...
    (0)
  • €10,49
  • 1x vendu
  • + en savoir plus
NURS 6521/NURS6521 Advanced Pharmacology Final Exam 2020/2021 Walden University
  • NURS 6521/NURS6521 Advanced Pharmacology Final Exam 2020/2021 Walden University

  • Examen • 14 pages • 2022
  • NURS 6521/NURS6521 Advanced Pharmacology Final Exam 2020/2021 Walden University Question 1 A 7-year-old child has been taking tetracycline for a bacterial infection. The nurse will be sure to inform the parents that this drug could cause Selected Answer: staining of permanent teeth.
    (0)
  • €17,65
  • 1x vendu
  • + en savoir plus
NURS 6521/NURS6521 Advanced Pharmacology Final Exam 2020/2021 Walden University
  • NURS 6521/NURS6521 Advanced Pharmacology Final Exam 2020/2021 Walden University

  • Examen • 14 pages • 2022
  • NURS 6521/NURS6521 Advanced Pharmacology Final Exam 2020/2021 Walden University Question 1 A 7-year-old child has been taking tetracycline for a bacterial infection. The nurse will be sure to inform the parents that this drug could cause Selected Answer: staining of permanent teeth.
    (0)
  • €17,65
  • + en savoir plus
NURS 6521 MIDTERM EXAM 2020 / NURS6521 MIDTERM EXAM 2020  (100 CORRECT Q & A , TOTAL: 75 Q & A)
  • NURS 6521 MIDTERM EXAM 2020 / NURS6521 MIDTERM EXAM 2020 (100 CORRECT Q & A , TOTAL: 75 Q & A)

  • Examen • 21 pages • 2020
  • PHARM NURS6521 Advanced Pharmacology A female patient is taking filgrastim (Neupogen) to decrease the incidence of infection. The nurse notices a small increase in the neutrophil count 2 days after starting therapy. The nurse's evaluation of the increase is that 1 points QUESTION 2 Which of the following patients will be at the greatest risk for anemia and would be the most likely candidate for epoetin alfa therapy? 1 points QUESTION 3 A male patient is receiving rituximab therapy for...
    (0)
  • €10,49
  • + en savoir plus